Elisabeth Leiderman
Directeur/Membre du Conseil chez BLUEBIRD BIO, INC.
Fortune : 20 320 $ au 30/04/2024
Postes actifs de Elisabeth Leiderman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BLUEBIRD BIO, INC. | Directeur/Membre du Conseil | 15/10/2021 | - |
| Independent Dir/Board Member | 15/10/2021 | - | |
| AUTOLUS THERAPEUTICS PLC | Directeur/Membre du Conseil | 20/12/2023 | - |
Historique de carrière de Elisabeth Leiderman
Anciens postes connus de Elisabeth Leiderman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Atsena Therapeutics, Inc.
 Atsena Therapeutics, Inc. BiotechnologyHealth Technology Atsena Therapeutics, Inc. engages in biotechnology business. The company is headquartered in Durham, NC. | Directeur Financier/CFO | 07/11/2022 | 01/11/2023 |
| DECIBEL THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 09/09/2021 | 07/10/2022 |
| Directeur Financier/CFO | 01/09/2020 | 07/10/2022 | |
Complexa, Inc.
 Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Corporate Officer/Principal | 01/11/2016 | 01/08/2020 |
| Nomura Securities, Inc. | Directeur/Membre du Conseil | 01/01/2013 | 01/07/2016 |
| FORTRESS BIOTECH, INC. | Corporate Officer/Principal | 01/01/2007 | 01/01/2016 |
Formation de Elisabeth Leiderman
| University of Pennsylvania | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Sackler School of Medicine | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 9 |
| Israël | 2 |
| Royaume-Uni | 2 |
Opérationnelle
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Director of Finance/CFO | 2 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| FORTRESS BIOTECH, INC. | Health Technology |
| DECIBEL THERAPEUTICS, INC. | Health Technology |
| BLUEBIRD BIO, INC. | Health Technology |
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| Entreprise privées | 3 |
|---|---|
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Health Technology |
| Nomura Securities, Inc. | |
Atsena Therapeutics, Inc.
Atsena Therapeutics, Inc. BiotechnologyHealth Technology Atsena Therapeutics, Inc. engages in biotechnology business. The company is headquartered in Durham, NC. | Health Technology |
- Bourse
- Insiders
- Elisabeth Leiderman
- Expérience
